Rosiglitazone hydrochloride
Rosiglitazone hydrochloride
Rosiglitazone hydrochloride listed in June 1999 in the United States, approved to treat type 2 diabetes.Within the first week after listed, rosiglitazone hydrochloride have entered the 20,000 pharmacies and received a warm welcome to the medical profession and patients. In 2000, in the first two months for doctors in the United States, more than 50 million patients opened more than 1.5 million prescriptions.
In 2002, rosiglitazone hydrochloride has been used in more than four million people with diabetes, global sales of 14.82 million dollars, beyond the global sales ranked second person insulin, become the global sales number one hypoglycemic products. In 2003, global sales of rosiglitazone hydrochloride 17.06 billion dollars, continue to comfortably in global diabetes drug all species and their dosage form ranked first name. Sales In 2004, rosiglitazone hydrochloride global sales of 24.89 billion dollars, continue to comfortably in global sales rank first name. Analysts expect to 2005, rosiglitazone hydrochloride sales will reach $30 billion.
Rosiglitazone hydrochloride has been completed pilot, process stability, convenient, post-treatment yield, high purity and end product purity meet FDA standards.
In 2002, rosiglitazone hydrochloride has been used in more than four million people with diabetes, global sales of 14.82 million dollars, beyond the global sales ranked second person insulin, become the global sales number one hypoglycemic products. In 2003, global sales of rosiglitazone hydrochloride 17.06 billion dollars, continue to comfortably in global diabetes drug all species and their dosage form ranked first name. Sales In 2004, rosiglitazone hydrochloride global sales of 24.89 billion dollars, continue to comfortably in global sales rank first name. Analysts expect to 2005, rosiglitazone hydrochloride sales will reach $30 billion.
Rosiglitazone hydrochloride has been completed pilot, process stability, convenient, post-treatment yield, high purity and end product purity meet FDA standards.